Sensititre YeastOne Caspofungin Susceptibility Testing of Candida Clinical Isolates: Correlation with Results of NCCLS M27-A2 Multicenter Study-Reference-Cited by-同舟云学术

Sensititre YeastOne Caspofungin Susceptibility Testing of Candida Clinical Isolates: Correlation with Results of NCCLS M27-A2 Multicenter Study

Published:2005-04 Issue:4 Volume:49 Page:1604-1607
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Cantón Emilia¹,Pemán Javier²,Gobernado Miguel²,Álvarez Elena³,Baquero Fernando³,Cisterna Ramón⁴,Gil Joaquina⁵,Martín-Mazuelos Estrella⁶,Rubio Carmen⁵,Sánchez-Sousa Aurora³,Serrano Carmen⁶

Affiliation:

1. Unidad de Microbiología Experimental-Centro de Investigación

2. Servicio de Microbiología, Hospital Universitario La Fe, Valencia

3. Hospital Universitario Ramón y Cajal, Madrid

4. Hospital Universitario Basurto, Bilbao

5. Hospital Clínico Universitario Lozano Blesa, Zaragoza

6. Hospital Universitario de Valme, Seville, Spain

Abstract

ABSTRACT The ability of Sensititre YeastOne to discriminate isolates with reduced caspofungin susceptibility was determined against 36 Candida spp. (6 with a known FKS1 mutation). Results were compared with those of M27-A2. The MIC endpoint was 100% growth inhibition. Overall agreement (±2 log 2 ) was 87.16%. Sensititre YeastOne detected strains with reduced caspofungin susceptibility.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.49.4.1604-1607.2005

Reference22 articles.

1. Quality Control Limits for Broth Microdilution Susceptibility Tests of Ten Antifungal Agents

2. Influences of Methodological Variables on Susceptibility Testing of Caspofungin against Candida Species and Aspergillus fumigatus

3. Fluconazole Susceptibilities of Bloodstream Candida sp. Isolates as Determined by National Committee for Clinical Laboratory Standards Method M27-A and Two Other Methods

4. Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors

5. Comparison of In Vitro Activities of the New Triazole SCH56592 and the Echinocandins MK-0991 (L-743,872) and LY303366 against Opportunistic Filamentous and Dimorphic Fungi and Yeasts

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Candida albicans targets that potentially synergize with fluconazole;Critical Reviews in Microbiology;2021-02-15

2. Fungal Drug Resistance Assays;Antimicrobial Drug Resistance;2017

3. Commercial Methods for Identification and Susceptibility Testing of Fungi;Manual of Commercial Methods in Clinical Microbiology;2016-04-01

4. The Resistant-Population Cutoff (RCOFF): a New Concept for Improved Characterization of Antimicrobial Susceptibility Patterns of Non-Wild-Type Bacterial Populations;Journal of Clinical Microbiology;2015-03-11

5. Multicenter Study of Anidulafungin and Micafungin MIC Distributions and Epidemiological Cutoff Values for Eight Candida Species and the CLSI M27-A3 Broth Microdilution Method;Antimicrobial Agents and Chemotherapy;2013-11-25